Controlled Release from Liquid Crystalline Phases
FULL PAPER
from comparison of the spectra for the two corresponding experiments
after the same time of equilibration in solution.
nol): l (e)=324 (11700), 264 (18000), 241 (12400), 232 (sh, 13100),
224 nm (14900); MS (EI): m/z (%): 238 ([M+1]+, 7), 237 ([M]+, 37),
195 (16), 194 (100), 193 (3), 91 (3), 90 (6), 89 (6), 77 (3).
Headspace measurements: The liquid crystalline phase mixture was pre-
pared by adding 20 mL of the volatiles to 200 mL of 1. A total of 100 mL
of the homogenised mixture was then placed onto the coated side of an
ITO-coated glass slide. To keep a constant distance between the two
slides, a Teflon film (0.1 mm thickness) was placed at each end of the
glass slide. The ITO glass slide was then covered with a second slide in
such a way that the coated side was in contact with the solution, and that
the slides were not completely superimposed on their smaller side (so as
to fix a crocodile clamp on opposite sides of each glass slide). The slides
were then pressed together to form a uniform and transparent film cover-
ing almost the whole surface between the slides. The set-up was taped to
a glass support and placed inside a home-made headspace sampling cell
(average volume ca. 625 mL) with the cables to the power supply passing
through a Teflon stopper at the top of the cell, allowing a gas-tight fixing
of the cables to the power supply. During the measurements, a constant
flow of air was aspirated through a set-up composed of a filter of activat-
ed carbon (Norit RB 1 0.6, pellets), a wash bottle containing a saturated
solution of NaCl (humidity of the air ca. 75%),[19] a second, empty wash
bottle, the headspace cell, and a Tenax cartridge containing 100 mg of
Tenax-TA (Varian). For the headspace sampling, a Gilian dual mode low
flow sampler pump was used, which was calibrated at a flow rate of
about 206 mLminÀ1. All measurements were carried out in triplicate, if
not stated otherwise, with the voltage on the power supply fixed at 60 or
75 V, respectively. The measurements were started by switching on the
pump and, after 1 min, the voltage. No current was measured on the
power supply during the experiment. The system was equilibrated for
10 min while sampling on a waste Tenax cartridge. After 10 min, the
waste cartridge was replaced with a clean one, and the volatiles were
trapped for 1 (cyclopentanol) or 2 min (all other compounds) onto a
clean cartridge. Then the waste cartridge was replaced. In each case a
control experiment was carried out in parallel under the same conditions,
without however applying any voltage to the ITO plates. Altogether 12
samples were taken. In the experiment with cyclopentanol, the sampling
was repeated every 29 min during 1 min, in all other experiments the
sampling was repeated every 28 min during 2 min. The cartridges were
thermally desorbed on a Perkin–Elmer TurboMatrix ATD desorber and
analysed on a Carlo Erba MFC 500 gas chromatograph equipped with a
I&W Scientific DB1 capillary column (30 m, i.d. 0.45 mm, film 0.42 mm)
and FID detector. The volatiles were analysed using a two-step tempera-
ture gradient starting from 708C to 1308C at 38CminÀ1 and then rising to
2608C at 258CminÀ1. The detector temperature was at 2608C. Headspace
concentrations (in ng per litre of air) were determined by external stan-
dard calibration. The calibrations were effected by using acetone solu-
tions at eight different concentrations; 0.4 mL of each calibration solution
were injected onto a clean Tenax cartridge. All the cartridges were desor-
bed immediately with increasing concentration under the same conditions
as those resulting from the headspace sampling. Plotting the concentra-
tions (in ngLÀ1) against the peak areas gave straight lines with a correla-
tion coefficient of r2 >0.992.
Synthesis of 4-butyl-N-[(1E)-(4-ethylphenyl)methylene]aniline (21): As
described for 20 with 4-ethylbenzaldehyde (17, 1.74 g, 13.0 mmol and
0.35 g, 2.6 mmol) to give
a
brownish oil (3.92 g (quant.)). 1H NMR
(400 MHz, CDCl3): d=8.44 (s, 1H), 7.81 (d, J=7.6 Hz, 2H), 7.29 (d, J=
8.2 Hz, 2H), 7.22–7.10 (m, 4H), 2.71 (q, J=7.5 Hz, 2H), 2.62 (t, J=
7.7 Hz, 2H), 1.67–1.56 (m, 2H), 1.37 (hex., J=7.5 Hz, 2H), 1.27 (t, J=
7.4 Hz, 3H), 0.94 ppm (t, J=7.4 Hz, 3H); 13C NMR (100.6 MHz, CDCl3):
d=159.59 (d), 149.83 (s), 147.93 (d), 140.66 (s), 134.06 (s), 129.08 (d),
128.81 (d), 128.30 (d), 120.78 (d), 35.19 (t), 33.72 (t), 28.95 (t), 22.35 (t),
15.39 (q), 13.98 ppm (q); IR (neat): n˜ =3049w, 3023w, 2959m, 2927m,
2871m, 2856m, 2730w, 1912w, 1898w, 1803w, 1772w, 1703w, 1626s,
1598m, 1568m, 1511m, 1502m, 1455m, 1417m, 1376w, 1363w, 1306w,
1260w, 1240w, 1192m, 1168s, 1112m, 1059m, 1050m, 1016m, 975m,
942w, 928w, 885m, 832s, 800m, 748m, 728m, 699w, 660w, 642w, 637w
cmÀ1; UV/Vis (ethanol): l (e)=319 (13600), 270 (19000), 226 (15000),
203 nm (28500); MS (EI): m/z (%): 266 ([M+1]+, 9), 265 ([M]+, 40),
223 (19), 222 (100), 207 (8), 206 (5), 91 (8), 90 (5), 89 (3), 77 (3).
Acknowledgements
We thank Dr. J.-Y. de Saint Laumer for the calculation of the vapour
pressures, B. Levrand for the preparation of compounds 20 and 21, and
Dr. Roger Snowden for constructive comments on the manuscript.
[1] a) Liquid Crystals Frontiers in Biomedical Applications (Eds.: S. J.
Woltman, G. P. Crawford, G. D. Jay), World Scientific Publishing,
Singapore, 2007; b) Special Issue on Liquid Crystals, Chem. Soc.
Rev. 2007, 1855–2124.
[2] For a selection of recent reviews, see for example: a) J. W. Goodby,
I. M. Saez, S. J. Cowling, V. Gçrtz, M. Draper, A. W. Hall, S. Sia, G.
poor, H.-J. Schneider, Intell. Mater. 2008, 491–505; d) S. J. Woltman,
Steinke, F. Giesselmann, C. Hꢄgele, G. Scalia, R. Judele, E. Kapatsi-
Khoo, A. Diaz, D. Kwon, D. H. Werner, J. Liou, M. Stinger, J. H.
b) C. I. Stevenson, D. B. Bennett, D. Lechuga-Ballesteros, J. Pharm.
285–305; d) C. C. Mꢅller-Goymann, Eur. J. Pharm. Biopharm. 2004,
58, 343–356; e) J. C. Shah Y. Sadhale, D. M. Chilukuri, Adv. Drug
[4] For a recent review see for example: J. Barauskas, T. Nylander in
Delivery and Controlled Release of Bioactives in Foods and Neutra-
ceuticals (Ed.: N. Garti), Woodhead Publishing, Cambridge, 2008.
350–353; b) L. Sagalowicz, M. E. Leser, H. J. Watzke, M. Michel,
Visani, P. Frossard, N. Garti, M. E. Leser, H. J. Watzke, J. Dispersion
Synthesis of 4-butyl-N-[(1E)-phenylmethylene]aniline (20): A solution of
4-butylaniline (2.0 g, 13.4 mmol) and benzaldehyde (16, techn., contain-
ing benzoic acid, 1.42 g, 13.4 mmol) in ethanol (150 mL) was heated
under reflux for 42–44 h. Then more 16 (0.71 g, 6.7 mmol) was added and
the mixture was left stirring under reflux overnight. After cooling to
room temperature, the reaction mixture was concentrated and the re-
maining volatiles were removed by bulb-to-bulb distillation to give a
brownish oil (3.47 g (quant.)). 1H NMR (400 MHz, CDCl3): d=8.47 (s,
1H), 7.92–7.85 (m, 2H), 7.49–7.42 (m, 3H), 7.23–7.12 (m, 4H), 2.63 (t,
J=7.9 Hz, 2H), 1.67-1.56 (m, 2H), 1.43–1.31 (m, 2H), 0.94 ppm (t, J=
7.4 Hz, 3H); 13C NMR (100.6 MHz, CDCl3): d=159.56 (d), 149.61 (s),
140.89 (s), 136.39 (s), 131.17 (d), 129.11 (d), 128.72 (d), 128.71 (d), 120.80
(d), 35.19 (t), 33.70 (t), 22.35 (t), 13.98 ppm (q); IR (neat): n˜ =3060w,
3024w, 2997w, 2955m, 2926m, 2870m, 2855m, 2731w, 1958w, 1897w,
1813w, 1759w, 1704w, 1627m, 1598m, 1577m, 1504m, 1464m, 1450m,
1416w, 1377w, 1365w, 1331w, 1311m, 1296w, 1236w, 1191m, 1168m,
1113m, 1071m, 1024w, 1015w, 1000w, 986w, 971m 927w, 916w, 882m,
781w, 754s, 727m, 689s, 667w, 652w, 638m, 626w cmÀ1; UV/Vis (etha-
[6] See for example: a) A. Madene, M. Jacquot, J. Scher, S. Desorby,
Int. J. Food Sci. Technol. 2006, 41, 1–21; b) S.-J. Park, R. Arshady,
Microspheres, Microcapsules Liposomes 2003, 6, 157–198; c) J. Ness,
O. Simonsen, K. Symes, Microspheres, Microcapsules Liposomes
Chem. Eur. J. 2009, 15, 117 – 124
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
123